This document outlines the components and development of clinical perfusion data (CPD) used during cardiopulmonary bypass procedures. It discusses how CPD has evolved from handwritten records to computerized databases to better organize patient information and physiology parameters recorded during procedures. CPD contains 5 key components: 1) patient demographics and risk factors, 2) procedure details, 3) frequent patient physiology measurements, 4) blood gas and anticoagulation monitoring results, and 5) signatures of the perfusionist and supervising physicians. The development of a centralized network storage and intranet system at the author's institution allowed for easier data entry, faster searching, and well-organized long-term storage of clinical perfusion records.
Value Analysis Committee Presentation (Branded) - PleuraFlow® ACT® SystemPaul Molloy
Presentation explaining how the PleuraFlow® ACT® System from ClearFlow,Inc.can Reduce Complications and Costs for your Cardiothoracic surgery patients.
Endovascular and surgical treatment of pulmonary embolism 26.11.17Ivo Petrov
Interventional treatment (thrombus fragmentation and supraselective fibrinolysis) of high and intermediate risk patients with pulmonary embolism.
Protocols of intervention, results, clinical cases provided
Perioperativebloodtransfusionsarecostlyandhavesafetyconcerns.Asa result, there have been multiple initiatives to reduce transfusion use. However, the degree to which perioperative transfusion rates vary among hospitals is unknown.
Objective Toassesshospital-levelvariationinuseofallogeneicredbloodcell(RBC), fresh-frozen plasma, and platelet transfusions in patients undergoing coronary artery bypass graft (CABG) surgery.
Struggling with intense fears that disrupt your life? At Renew Life Hypnosis, we offer specialized hypnosis to overcome fear. Phobias are exaggerated fears, often stemming from past traumas or learned behaviors. Hypnotherapy addresses these deep-seated fears by accessing the subconscious mind, helping you change your reactions to phobic triggers. Our expert therapists guide you into a state of deep relaxation, allowing you to transform your responses and reduce anxiety. Experience increased confidence and freedom from phobias with our personalized approach. Ready to live a fear-free life? Visit us at Renew Life Hypnosis..
CRISPR-Cas9, a revolutionary gene-editing tool, holds immense potential to reshape medicine, agriculture, and our understanding of life. But like any powerful tool, it comes with ethical considerations.
Unveiling CRISPR: This naturally occurring bacterial defense system (crRNA & Cas9 protein) fights viruses. Scientists repurposed it for precise gene editing (correction, deletion, insertion) by targeting specific DNA sequences.
The Promise: CRISPR offers exciting possibilities:
Gene Therapy: Correcting genetic diseases like cystic fibrosis.
Agriculture: Engineering crops resistant to pests and harsh environments.
Research: Studying gene function to unlock new knowledge.
The Peril: Ethical concerns demand attention:
Off-target Effects: Unintended DNA edits can have unforeseen consequences.
Eugenics: Misusing CRISPR for designer babies raises social and ethical questions.
Equity: High costs could limit access to this potentially life-saving technology.
The Path Forward: Responsible development is crucial:
International Collaboration: Clear guidelines are needed for research and human trials.
Public Education: Open discussions ensure informed decisions about CRISPR.
Prioritize Safety and Ethics: Safety and ethical principles must be paramount.
CRISPR offers a powerful tool for a better future, but responsible development and addressing ethical concerns are essential. By prioritizing safety, fostering open dialogue, and ensuring equitable access, we can harness CRISPR's power for the benefit of all. (2998 characters)
The dimensions of healthcare quality refer to various attributes or aspects that define the standard of healthcare services. These dimensions are used to evaluate, measure, and improve the quality of care provided to patients. A comprehensive understanding of these dimensions ensures that healthcare systems can address various aspects of patient care effectively and holistically. Dimensions of Healthcare Quality and Performance of care include the following; Appropriateness, Availability, Competence, Continuity, Effectiveness, Efficiency, Efficacy, Prevention, Respect and Care, Safety as well as Timeliness.
How many patients does case series should have In comparison to case reports.pdfpubrica101
Pubrica’s team of researchers and writers create scientific and medical research articles, which may be important resources for authors and practitioners. Pubrica medical writers assist you in creating and revising the introduction by alerting the reader to gaps in the chosen study subject. Our professionals understand the order in which the hypothesis topic is followed by the broad subject, the issue, and the backdrop.
https://pubrica.com/academy/case-study-or-series/how-many-patients-does-case-series-should-have-in-comparison-to-case-reports/
Defecation
Normal defecation begins with movement in the left colon, moving stool toward the anus. When stool reaches the rectum, the distention causes relaxation of the internal sphincter and an awareness of the need to defecate. At the time of defecation, the external sphincter relaxes, and abdominal muscles contract, increasing intrarectal pressure and forcing the stool out
The Valsalva maneuver exerts pressure to expel faeces through a voluntary contraction of the abdominal muscles while maintaining forced expiration against a closed airway. Patients with cardiovascular disease, glaucoma, increased intracranial pressure, or a new surgical wound are at greater risk for cardiac dysrhythmias and elevated blood pressure with the Valsalva maneuver and need to avoid straining to pass the stool.
Normal defecation is painless, resulting in passage of soft, formed stool
CONSTIPATION
Constipation is a symptom, not a disease. Improper diet, reduced fluid intake, lack of exercise, and certain medications can cause constipation. For example, patients receiving opiates for pain after surgery often require a stool softener or laxative to prevent constipation. The signs of constipation include infrequent bowel movements (less than every 3 days), difficulty passing stools, excessive straining, inability to defecate at will, and hard feaces
IMPACTION
Fecal impaction results from unrelieved constipation. It is a collection of hardened feces wedged in the rectum that a person cannot expel. In cases of severe impaction the mass extends up into the sigmoid colon.
DIARRHEA
Diarrhea is an increase in the number of stools and the passage of liquid, unformed feces. It is associated with disorders affecting digestion, absorption, and secretion in the GI tract. Intestinal contents pass through the small and large intestine too quickly to allow for the usual absorption of fluid and nutrients. Irritation within the colon results in increased mucus secretion. As a result, feces become watery, and the patient is unable to control the urge to defecate. Normally an anal bag is safe and effective in long-term treatment of patients with fecal incontinence at home, in hospice, or in the hospital. Fecal incontinence is expensive and a potentially dangerous condition in terms of contamination and risk of skin ulceration
HEMORRHOIDS
Hemorrhoids are dilated, engorged veins in the lining of the rectum. They are either external or internal.
FLATULENCE
As gas accumulates in the lumen of the intestines, the bowel wall stretches and distends (flatulence). It is a common cause of abdominal fullness, pain, and cramping. Normally intestinal gas escapes through the mouth (belching) or the anus (passing of flatus)
FECAL INCONTINENCE
Fecal incontinence is the inability to control passage of feces and gas from the anus. Incontinence harms a patient’s body image
PREPARATION AND GIVING OF LAXATIVESACCORDING TO POTTER AND PERRY,
An enema is the instillation of a solution into the rectum and sig
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...Dr. David Greene Arizona
As we watch Dr. Greene's continued efforts and research in Arizona, it's clear that stem cell therapy holds a promising key to unlocking new doors in the treatment of kidney disease. With each study and trial, we step closer to a world where kidney disease is no longer a life sentence but a treatable condition, thanks to pioneers like Dr. David Greene.
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
We understand the unique challenges pickleball players face and are committed to helping you stay healthy and active. In this presentation, we’ll explore the three most common pickleball injuries and provide strategies for prevention and treatment.
Welcome to Secret Tantric, London’s finest VIP Massage agency. Since we first opened our doors, we have provided the ultimate erotic massage experience to innumerable clients, each one searching for the very best sensual massage in London. We come by this reputation honestly with a dynamic team of the city’s most beautiful masseuses.
Navigating the Health Insurance Market_ Understanding Trends and Options.pdfEnterprise Wired
From navigating policy options to staying informed about industry trends, this comprehensive guide explores everything you need to know about the health insurance market.
2. 1. Introduction
2. Definition of Clinical Perfusion Data
3. Development in Our Setting
4. Components of CPD
5. Conclusion
6. Short Demonstration
OUTLINE
3. WHAT IS A PERFUSIONIST ?
PERFUSIONISTS
Operate the heart lung machine,
Monitoring and controlling oxygen
levels, blood pressure, body
temperature and blood flow.
They also administer anesthetics and
other drugs during surgery.
(Prof. Michael Smith
Quinnipiac University School of Health Sciences)
4. Perfusion data is one of the major standards
recommendations of monitoring during
cardiopulmonary bypass (CPB).
(Society of Clinical Perfusion Scientists
of Great Britain & Ireland, 2007)
This includes monitoring for the onset of and
weaning from CPB,
confirmation of anticoagulation
and ventilation of the lungs.
(Association of Cardiothoracic Anesthetics & Society for Cardiothoracic Surgeon in Great Britain &
Ireland, 2007)
INTRODUCTION
5. Perfusion data can defined as:
The perfusion record (written or electronic) for
each (CPB) procedure
which shall be included as part of patient’s
permanent medical record.
(American Society of ExtraCorporeal Technology, 2013)
…..is a legal presentation of the procedure,
whether manually recorded or computerized
which should be maintained & stored
in patient's notes, according to institution policy
for retaining medical records.
(Society of Clinical Perfusion Scientists
of Great Britain & Ireland, 2007)
WHAT IS CLINICAL PERFUSION DATA (CPD)?
6. DEVELOPMENT IN OUR SETTING:
HANDWRITTEN CLINICAL PERFUSION DATA
DISADVANTAG
ES
Difficult in
storage –
filing system
Bad Hand
writing
Searching gets
difficult as the
filing gets more.
1996
till
1998
8. COMPUTERISED CLINICAL PERFUSION DATA
( EXCEL) … CONTINUE
DISADVANTAGES
Big files required
more Hard-disk
space
Takes a long time
for searching data
Not able to keep
data in sequent
format
Difficult to track such as:
- number of pump run by
perfusionist
- number of case
in respective
groups
- difficult to compile Data
as each OT’s has got
individual PCs
9. OUR DEVELOPMENT: COMPUTERISED
CLINICAL PERFUSION DATA (DATABASE)
Database records are
divided into fields,
which makes searching
the databases easier.
What goes into each
field varies depending
on the type of literature
we’re documenting.
ADVANTAGES
- Easier to key in data
- Searching made
simpler and faster
- Well organized data
no matter how long the
files are.
18. COMPONENT OF CPD
1. Patient information
(demographics & pre-operative risk factors).
2. Information describing :-
(procedure, personnel & equipment ).
3. Patient physiology parameters
(documented at a frequency determined by institutional protocol).
4. Blood gas & anticoagulation monitoring results.
5. Signature of the perfusionist (include relief).
(American Society of ExtraCorporeal Technology, 2013)
19. 1. PATIENT INFORMATION, DEMOGRAPHICS &
PRE-OPERATIVE RISK FACTORS
Perfusion Record: Includes Single Entry Information
Medical Record Number ( RN).
Patient Name.
Demographics. ( Age, Gender, Height , Weight, Body
Surface Area (BSA)
Laboratory Data. ( Hematocrit, Predicted Hematocrit on Bypass)
Patient Allergies.
Planned Procedure.
Medical History/ Risk Factors. (Cardiovascular, Renal, Neurologic, GI Track).
1
20. 2. INFORMATION DESCRIBING PROCEDURE,
PERSONAL & EQUIPMENT
Perfusion Record:
Includes Single Entry And Recorded Lot Number.
Record Lot Number
Equipment –
Heart Lung Machine
Disposables:
- Oxygenator
- Tubing pack/
Arterial Line Filter
- Centrifugal Pump Head
- Ultrafiltration Device
- Arterial & Venous Cannulae
Single Entry
• Date of Procedure
• Type of Procedure
• Perfusionist’s Name
• Surgeon’s Name
• Anaesthesiologist's Name
• Nurse’s Name
• Operating Room Name
• Comments/Events
2
24. 4. BLOOD GAS & ANTICOAGULATION
MONITORING RESULTS
Perfusion Record:
Includes Multiple Entry Information For Laboratory
Values At Least Every 30 Minutes
Arterial or venous blood Gases
Venous Oxygen Saturation
Potassium Concentration
Haemoglobin /Haematocrit
Anticoagulation monitoring - Activated Clotting Times
(ACT) and/or Heparin level.
26. 4. BLOOD GAS & ANTICOAGULATION
MONITORING RESULTS…CONTINUE
Perfusion Record:
Includes Intermittent Information Entry At
Appropriate Time
Input fluid volumes – Blood Product
– Prime fluids
– Fluid Added
Output fluids – Urine output
– Ultrafiltration
Perfusionist Administered Medication
4
27.
28. 5. SIGNATURE OF THE PERFUSIONIST
Signature of the perfusionist
(and all relief perfusionists) performing
the procedure.
Include the signature of physician(s) providing
supervision for the CPB procedure.
5
29. 21/9/2013 29
It is the responsibility of the clinical perfusionist to assist the
Surgeon/physician in any way possible in patient care
& particularly within the defined areas of expertise
of the clinical perfusionist ….
(The American Academy of Cardiovascular Perfusion, 2008)
CONCLUSION
31. REFERENCES:
Banbury, M.,White J., Blackstone, E., & Cosgrovo, D. (2003)Vacuum-assisted venous return reduces blood usage. Journal
ofThoracic Cardiovascular Surgery.Vol. 126 (3), pp:680-687.
Jegger, D.,Tevaearai, H.T., Mueller, X.M., Horisberger, J., & von Segesser, LK. (2003).
Limitations using the vacuum-assist venous drainage technique during cardiopulmonary
bypass procedures. The Journal Of Extra-corporealTechnology. Vol. 35 (3), pp: 207 – 211.
Munster, K., Anderson, U., Mikkelsen, J., & Petterson,G.(1999).Vacuum AssistedVenous Drainage
(VAVD). University of Copenhagen and Hamlet Private Hospital.
Vol. 14 (6), pp: 419 – 423.
Shigang Wang & Akif Undar (2009). Vacuum-assisted venous drainage and gaseous microemboli in
pulmonary bypass. The Journal Of Extra-corporealTechnology. Vol. 40 (4), pp: 249 – 256.
Sintya,T. et al. (2011). Vacuum-assisted venous drainage in cardiopulmonary bypass and need of blood transfusion:
experience of service. Brazilian Journal of Cardiovascular Surgery.Vol. 26 (1).
Willcox,T. (2013).Vacuum Assist:Angel or Demon CON. The Journal Of Extra-corporeal
Technology. Vol. 45 (2), pp: 128 – 141.
Willcox,T. (2002).Vacuum-assisted venous drainage: to air or not to air, that is the question.
Has the bubble burst? The Journal Of Extra-corporealTechnology. Vol. 34, pp: 24–28.
Y Hayashi et al. (2001). Clinical application of vacuum-assisted cardiopulmonary bypass with a pressure
relief valve. European Journal of Cardio-Thoracic Surgery.Vol. 20 (3), pp: 621 - 627. .
21/9/2013 31
32.
33. GET SOME CHAT SLIDES READY in
case the video doesn’t work